You just read:

Aptinyx Awarded Up to $2.85 Million in NIH Grants to Research NMDA Receptor Modulation for the Treatment of Neuropathic Pain and Age-Related Cognitive Decline

News provided by

Aptinyx Inc.

Nov 10, 2016, 08:00 ET